I now have comprehensive information from three authoritative sources. Let me compile the complete answer.
Paediatric SVT Management & Weight-Based Drug Dosing
Definition & Recognition
| Feature | Sinus Tachycardia | SVT |
|---|
| P waves | Present | Absent or retrograde |
| Rate (infants) | Usually <220 bpm | Usually >220 bpm |
| Rate (children) | Usually <180 bpm | Usually >180 bpm |
| Beat-to-beat variability | Yes | No (constant R-R intervals) |
| Precipitating event | Fever, pain, dehydration | None |
Most paediatric SVT is AVRT (AV re-entrant tachycardia) using an accessory pathway — Wolff-Parkinson-White is present in 10–20%. Narrow QRS complex is typical (orthodromic); wide QRS occurs in antidromic SVT or pre-existing bundle branch block.
Step-by-Step Management Algorithm
UNSTABLE (altered mental status, poor perfusion, hypotension, pallor, cyanosis)
→ Immediate Synchronised Cardioversion
| Attempt | Energy |
|---|
| 1st | 0.5–1 J/kg |
| 2nd | 1–2 J/kg |
Sedate if time permits; do not delay cardioversion for sedation in a critically unstable child.
STABLE (adequate perfusion)
Step 1 — Vagal Maneuvers (attempt first in all stable patients)
- Ice pack to face (infants): Bag/glove filled with ice-water slurry applied to forehead, eyes, bridge of nose for 10–15 seconds (do not occlude nose/mouth). Most effective in infants.
- Valsalva maneuver (older children): Exhale forcefully against closed glottis for 10–15 seconds in supine position.
- Modified Valsalva: Standard Valsalva at 45° → immediately supine + passive leg raise at 45° for 15 seconds. Higher success than standard Valsalva.
- Carotid sinus massage: Avoid in infants; not recommended in children.
- Blowing into a syringe: Effective vagal maneuver in children.
Step 2 — Adenosine (if vagal maneuvers fail)
Must be given as rapid IV bolus followed immediately by a rapid NS flush (use the most proximal vein available — antecubital or central).
| Dose | mg/kg | Maximum |
|---|
| 1st dose | 0.1 mg/kg | 6 mg |
| 2nd dose (if 1st fails) | 0.2 mg/kg | 12 mg |
| 3rd dose (repeat 2nd if needed) | 0.2 mg/kg | 12 mg |
- Half-life ~10 seconds — flush rapidly and document rhythm strip throughout.
- May cause transient wide-complex tachycardia (antidromic conduction via accessory pathway) — usually self-terminating; observe closely.
- If adenosine fails → elective synchronised cardioversion under procedural sedation.
Step 3 — Amiodarone (adenosine-refractory or recurrent SVT)
| Dose | Route | Notes |
|---|
| 5 mg/kg loading dose | IV over 20–60 min | Consult paediatric cardiologist |
Other Rhythm-Specific Dosing
Atrial Flutter / Atrial Fibrillation (rare in children)
- Unstable: Synchronised cardioversion (0.5–1 J/kg, up to 2 J/kg)
- Stable, rate control: Diltiazem, beta-blockers, or digoxin (slow ventricular response first)
- ⚠️ WPW + AF/flutter: Avoid adenosine, amiodarone, beta-blockers, calcium channel blockers, digoxin (the "A-B-C-D" drugs) — these block the AV node and may allow rapid accessory pathway conduction → VF. Use procainamide or cardioversion instead.
Torsades de Pointes (polymorphic VT with long QT)
| Drug | Dose | Route |
|---|
| Magnesium sulfate | 25–50 mg/kg (max 2 g) | IV over 2 minutes |
⚠️ Procainamide and amiodarone are contraindicated in TdP (prolong QT further).
SVT in Post-Cardiac Surgery Children
SVT is common after atriotomy procedures (Fontan, Senning, Mustard, ASD repair). Management is the same:
- Stable: Adenosine 0.1 mg/kg IV rapid bolus (max 12 mg)
- Unstable: Synchronised cardioversion 0.5–1 J/kg (up to 2 J/kg)
Quick Reference Summary
| Drug | 1st dose (mg/kg) | Max 1st dose | 2nd dose (mg/kg) | Max 2nd dose |
|---|
| Adenosine | 0.1 mg/kg | 6 mg | 0.2 mg/kg | 12 mg |
| Amiodarone | 5 mg/kg IV | — | — | — |
| Magnesium (TdP) | 25–50 mg/kg | 2 g | — | — |
| Cardioversion (SVT) | 0.5–1 J/kg | — | 1–2 J/kg | — |
Sources: Rosen's Emergency Medicine, 9th ed. — p.3214–3215; Tintinalli's Emergency Medicine, 9th ed. — p.870; The Harriet Lane Handbook, 23rd ed. — p.234